
VTGN
USDVistagen Therapeutics Inc. Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$4.180
उच्च
$4.296
कम
$4.060
मात्रा
0.21M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
124.9M
उद्योग
जैव प्रौद्योगिकी
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
0.57M
एक्सचेंज
NCM
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
Topline results for the trial are expected by year end Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a
संबंधित स्टॉक
EVT
Eaton Vance Tax Advantaged Dividend Income Fund Common Shares of Beneficial Interest
PWUPW
PowerUp Acquisition Corp. Warrant
WLKP
Westlake Chemical Partners LP Common Units representing limited partner interests
IBTX
Independent Bank Group Inc
SCCD
Sachem Capital Corp. 6.00% Notes due 2026
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।